none

3D PEN PRINTS NEW KNEE JOINTS

06-06-2017
by 
in 

3D-Printing pens have been a gimmick for artists until now, but new breakthroughs have pushed this novelty tech into the medical arena. 

 Several Australian institutions, including the University of Wollongong, St. Vincent’s Hospital Melbourne and its Aikenhead Centre for Medical Discovery (ACMD), teamed up in 2016 to develop the BioPen; a 3D printing pen filled with stem cells that allows surgeons to draw new cartilage into injured knees.

Testing has been extensive, and Melbourne surgeons have successfully tested this bioprinting pen on six sheep.

The BioPen uses an ink that’s similar to toothpaste, which mixes a gelatine substance with stem cells taken from the patient on the day of the surgery.

Dr. Claudia Di Bella, an orthopaedic surgeon at St. Vincent’s Hospital, said, “[The pen] prints that in a material which is called hydrogel that allows your cells not just to survive but also increase in numbers and then make certain types of tissues, and in our case cartilage. The goal would be to try and repair certain injuries like cartilage injuries that at the moment are impossible to repair completely.”

These stem cells, put directly onto damaged areas, grow into the exact kind of tissue that’s necessary – currently, it’s knee cartilage.

After placement, an ultraviolet light, affixed to the pen, dries the ink mixture on contact so surgeons can fill in the damaged area of the knee and build up layers. The BioPen was recently tested by treating 1 cm cartilage tears in six sheep, which were suffering from knee injuries not unlike those common to Australian football players.

After a brief rehabilitation, the sheep were found to have regrown cartilage that was much stronger than the repair cartilage that grows after current treatments; the sheep were doing so well, in fact, that they were able to bear weight.

Philip Dalidakis, Victoria’s Small Business, Innovation, and Trade Minister, called the breakthrough astounding.

During the sheep trials, Dr. Di Bella said that the technology was easy to use, and that surgeons did not run into any complications.

The hope is for human trials for the BioPen to start within a year, with results of the sheep trials being used to justify a grant from the National Health and Medical Research Council, which would be used to “perfect the treatment over the next three years.”

Related news & editorials

  1. 14.12.2018
    14.12.2018
    by      In
    The convenience of opening doors or logging onto computers with the wave of a hand is now possible with new technology that enables humans to be microchipped.
    A human microchip is the size of a grain of rice and it is implanted into the hand, between the thumb and forefinger, in a quick and fairly... Read More
  2. 14.12.2018
    14.12.2018
    by      In
    An additional $500,000 Federal Government investment is set to allow Deakin’s ManuFutures advanced manufacturing business incubator to set up a new acceleration programme for its members. The new ManuFutures Export Acceleration Programme (MEAP) will support the emerging businesses to strengthen... Read More
  3. 13.12.2018
    13.12.2018
    by      In
    After a long stint as the Asia-Pacific Managing Director of 600 Machine Tools, Cliff Purser is retiring from his post in Sydney, and returning to live in New Zealand.
    The genial Englishman has led the 600 team in Australia since transferring in November 2004 from the position of New Zealand... Read More
  4. 13.12.2018
    13.12.2018
    by      In
    Adelaide has been chosen as the headquarters of the newly established Australian Space Agency.
    The Australian Space Agency was officially launched on 1st July and received $41 million over four years from 2018-19 in the federal budget to “grow the Australian space industry,” including $26 million... Read More